Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Japanese Healthcare Q&A (1)
October 6, 2003
- BUSINESS NEWS IN BRIEF
October 6, 2003
- WEBSITE NEWS
October 6, 2003
- Chuikyo Starts Discussion to Review NHI Pricing Rule
October 6, 2003
- PFSB to Beef Up NDA Review, Safety Measures, Victim Relief via New Drug Organization
October 6, 2003
- Chuikyo Committee Approves Draft Questionnaire on New Medical Technologies
September 29, 2003
- Dear-Doctor Letter Ordered for Intestinal Cleanser Niflec
September 29, 2003
- Hepatitis C Found in 1.6% of People Screened: Survey
September 29, 2003
- REGULATORY NEWS IN BRIEF
September 29, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 29, 2003
- NEW PRODUCTS
September 29, 2003
- Nihon Schering Establishing New Research Center in Kobe
September 29, 2003
- Meet the Leaders (25)
September 29, 2003
- Kurume Univ. to Begin Course in Biostatistics
September 29, 2003
- WORLD NEWS IN BRIEF
September 29, 2003
- PRESS SEMINAR
September 29, 2003
- Boosting Awareness of Migraine Key to Maxalt Promotion: Eisai
September 29, 2003
- JACDS Proposes OTC Drug Reclassification for Sales Deregulation
September 29, 2003
- Banyu to Provide Tailor-made Evidence to Boost Nu-lotan
September 29, 2003
- Free OTC Drugs Supply via Videophone Violates PAL?
September 29, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…